SCHEMBL18629024

SCHEMBL18629024

COC(=O)C1CC(=O)CCN1C(O)OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 1/20 0.43
▸ ANPEP P15144 1/20 0.43
▸ CYP3A4 P08684 2/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ FKBP1A P62942 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.38
▸ KLK5 Q9Y337 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ LTA4H P09960 2/20 0.38
▸ MITF O75030 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ TRPM8 Q7Z2W7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26296615 0.82 FKBP1A (0.49) CYP3A4FKBP1AALDH1A1KLK5TSHR
SCHEMBL17643432 0.82 CYP2C19 (0.44) CYP3A4CYP2C9CYP2C19FKBP1AALDH1A1
SCHEMBL16277574 0.78 MMP2 (0.46) MMP2ANPEPCYP3A4CYP2C19ALDH1A1
SCHEMBL16282515 0.78 MMP2 (0.46) MMP2ANPEPCYP3A4CYP2C19ALDH1A1
SCHEMBL26310890 0.78 NPSR1 (0.49) FKBP1AALDH1A1TSHRMAPTNPSR1
SCHEMBL2126991 0.78 NPSR1 (0.49) FKBP1AALDH1A1TSHRMAPTNPSR1
SCHEMBL31561934 0.77 FKBP1A (0.49) MMP2ANPEPFKBP1AALDH1A1MAPT
SCHEMBL26502806 0.76 FKBP1A (0.43) MMP2ANPEPCYP3A4CYP2C9CYP2C19
SCHEMBL17009205 0.75 LTA4H (0.47) MMP2ANPEPFKBP1AALDH1A1LTA4H
SCHEMBL27546320 0.72 MMP2 (0.50) MMP2ANPEPCYP2C19FKBP1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3141252-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION Vertex Pharmaceuticals Inc. (US) 2017-03-15 — — EP disclosed
Send feedback